SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of segment revenues and profit

Segment revenues and profits were as follows:

	Three Months Ended March 31,
(in millions)	2023		2022
Revenues:
Salix	$	496	$	464
International	247		244
Solta Medical	73		72
Diversified	197		249
Bausch + Lomb	931		889
	$	1,944	$	1,918
Segment profits:
Salix	$	314	$	322
International	77		91
Solta Medical	36		35
Diversified	107		158
Bausch + Lomb	211		206
	745		812
Corporate	(251)		(194)
Amortization of intangible assets	(273)		(310)
Asset impairments	(13)		(8)
Restructuring, integration, separation and IPO costs	(10)		(13)
Other expense, net	(23)		(2)
Operating income	175		285
Interest income	6		2
Interest expense	(307)		(362)
Foreign exchange and other	(10)		(7)
Loss before income taxes	$	(136)	$	(82)

Schedule of revenues by segment and product category

Revenues by segment and product category were as follows:

(in millions)	Salix		International		Solta Medical		Diversified		Bausch + Lomb		Total
	Three Months Ended March 31, 2023
Pharmaceuticals	$	496	$	57	$	—	$	162	$	108	$	823
Devices	—		—		73		—		406		479
OTC	—		39		—		2		353		394
Branded and Other Generics	—		138		—		27		61		226
Other revenues	—		13		—		6		3		22
	$	496	$	247	$	73	$	197	$	931	$	1,944
	Three Months Ended March 31, 2022
Pharmaceuticals	$	464	$	58	$	—	$	205	$	107	$	834
Devices	—		—		72		—		386		458
OTC	—		38		—		2		336		376
Branded and Other Generics	—		133		—		36		54		223
Other revenues	—		15		—		6		6		27
	$	464	$	244	$	72	$	249	$	889	$	1,918

Schedule of revenue attributed to a geographic region

Revenues are attributed to a geographic region based on the location of the customer and were as follows:

	Three Months Ended March 31,
(in millions)	2023		2022
U.S. and Puerto Rico	$	1,111	$	1,115
China	88		103
Canada	84		78
Poland	75		76
Mexico	69		61
France	57		57
Japan	50		51
Germany	43		45
United Kingdom	30		28
Russia	34		25
Spain	22		21
Italy	21		20
South Korea	22		19
Other	238		219
	$	1,944	$	1,918

Schedule of customers that accounted for 10% or more of total revenue

Customers that accounted for 10% or more of total revenues were as follows:

	Three Months Ended March 31,
	2023	2022
AmerisourceBergen Corporation	19%	18%
McKesson Corporation (including McKesson Specialty)	14%	14%
Cardinal Health, Inc.	13%	13%